Leverage the PCRplus Advantage at Your Urgent Care Clinic

Cepheid’s GeneXpert®Xpress system and CLIA waived respiratory test menu deliver lab-quality PCR results to improve patient outcomes and drive operational efficiencies.

 

Xpert® Xpress CoV-2 plus*

Xpert® Xpress CoV-2/Flu/RSV plus*

Xpert® Xpress Strep A

 


 

watch
WATCH VIDEO:
Multiplex PCR Testing to Differentiate Your Urgent Care
watch
WATCH VIDEO:
Video Demonstration of GeneXpert Xpress system
download
DOWNLOAD BROCHURE:
RT-PCR in Urgent Care
test-menu
SEE CRITICAL INFECTIONS TEST MENU:
Our portfolio of easy-to-use, on-demand tests

Choose the PCRplus advantage.

  • Accurate results that clinicians and patients can rely on.

  • Speed and efficiency to deliver on-demand answers WHEN they are needed most.

  • A flexible delivery platform, like the GeneXpert® system and Xpert® test cartridges that can deliver those results WHERE they are needed, from the lab to the point of care.

  • Quality of test design has a proven track record of delivering quality across a broad menu of test products. Experience matters.

  • Simplicity that provides a solution that is easy to learn, adopt, and operate across a variety of settings and users.

US-IVD In Vitro Diagnostic Test.
* These tests have not been FDA cleared or approved. These tests have been authorized by FDA under an EUA for use by authorized laboratories. Xpert Xpress CoV-2 plus has been authorized only for the detection of nucleic acids from SARS-CoV-2, and not for any other viruses or pathogens. Xpert Xpress CoV-2/Flu/RSV plus has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acids from SARS-CoV-2, influenza A, influenza B, and respiratory syncytial virus (RSV), and not for any other viruses or pathogens. The emergency use of these products is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.

Request a Demo

In submitting this form, you agree to be contacted by Cepheid to receive information on products, goods, and services, which may include similar products, goods, or services from our affiliates. Cepheid processes your personal data to send you the requested information. You have rights regarding your personal data, and consent may be withdrawn at any time. For additional information about how Cepheid handles your personal data, please review our online privacy policy.